glp-1 obesity drug news updates U.S. Rate Drops as Use of Weight Loss Drugs Surges | National GLP-1s and the Unintended Consequences

Explore Humana's coverage of Semaglutide (Wegovy), reasons for denial, steps to secure coverage, cost without insurance, and FAQs.

Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years

There have been and continue to be advances in the GLP-1 pipeline.

Understand their differences in efficacy and safety.

It has been studied in human clinical trials and shown to support metabolic balance, healthy blood glucose regulation, inflammation management, and improved insulin function

As California ends Medicaid coverage for GLP-1 weight loss drugs likeWegovy and Zepbound, experts say the states advice to simply eat better isnt realistic for many patients.